Thursday, June 11, 2026

Patent directory Β· USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,769
Drugs linked 4,797

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code β€” or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 71 of 1,261
  1. US 12188048

    Restimulation of cryopreserved tumor infiltrating lymphocytes

    Iovance Biotherapeutics, Inc. Β· Granted Jan 7, 2025 Β· Expires Jan 2, 2045

    granted
  2. US 12186285

    Compositions and methods of treatment for tinea pedis

    Compass Therapeutics LLC Β· Granted Jan 7, 2025 Β· Expires Jan 2, 2045

    granted
  3. US 12187779

    Anti-human papillomavirus 16 E6 T cell receptors

    The United States of America, as represented by the Secretary, Department of Health and Human Services Β· Granted Jan 7, 2025 Β· Expires Jan 2, 2045

    granted
  4. US 12187804

    Multivalent and multispecific 41BB-binding proteins

    Inhibrx Biosciences, Inc. Β· Granted Jan 7, 2025 Β· Expires Jan 2, 2045

    granted
  5. US 12188926

    Stimuli responsive microsphere composites

    SOUTH DAKOTA BOARD OF REGENTS Β· Granted Jan 7, 2025 Β· Expires Jan 2, 2045

    granted
  6. US 12188948

    Metabolite biomarkers for diseases associated with the contact activation system

    Takeda Pharmaceutical Company Limited Β· Granted Jan 7, 2025 Β· Expires Jan 2, 2045

    granted
  7. US 12187782

    PDL1 peptides for use in cancer vaccines

    IO Biotech ApS Β· Granted Jan 7, 2025 Β· Expires Jan 2, 2045

    granted
  8. US 12187815

    Anti-inflammatory nanofibers

    Northwestern University Β· Granted Jan 7, 2025 Β· Expires Jan 2, 2045

    granted
  9. US 12187762

    Dithiolsaccharide mucolytic agents and uses thereof

    The Regents of the University of California Β· Granted Jan 7, 2025 Β· Expires Jan 2, 2045

    granted
  10. US 12187739

    Diaryl macrocycle polymorph

    TURNING POINT THERAPEUTICS, INC. Β· Granted Jan 7, 2025 Β· Expires Jan 2, 2045

    granted
  11. US 12188060

    Messenger RNA encoding Cas9 for use in genome-editing systems

    CRISPR THERAPEUTICS AG Β· Granted Jan 7, 2025 Β· Expires Jan 2, 2045

    granted
  12. US 12188058

    Manufacture of active highly phosphorylated human lysosomal sulfatase enzymes and uses thereof

    BIOMARIN PHARMACEUTICAL INC. Β· Granted Jan 7, 2025 Β· Expires Jan 2, 2045

    granted
  13. US 12188039

    Recombinant adeno-associated viral vector for gene delivery

    The Board of Regents of the University of Texas System Β· Granted Jan 7, 2025 Β· Expires Jan 2, 2045

    granted
  14. US 12187799

    Dual specificity antibodies to PD-L1 and PD-L2 and methods of use therefor

    The Board of Regents of the University of Texas System Β· Granted Jan 7, 2025 Β· Expires Jan 2, 2045

    granted
  15. US 12187792

    IL-4/IL-13 pathway inhibitors for enhanced efficacy in treating cancer

    REGENERON PHARMACEUTICALS, INC. Β· Granted Jan 7, 2025 Β· Expires Jan 2, 2045

    granted
  16. US 12188020

    Methods for reducing Ataxin-2 expression

    Ionis Pharmaceuticals, Inc. Β· Granted Jan 7, 2025 Β· Expires Jan 2, 2045

    granted
  17. US 12187772

    IL10 agonists and methods of use thereof

    REGENERON PHARMACEUTICALS, INC. Β· Granted Jan 7, 2025 Β· Expires Jan 2, 2045

    granted
  18. US 12187769

    Cell

    AUTOLUS LIMITED Β· Granted Jan 7, 2025 Β· Expires Jan 2, 2045

    granted
  19. US 12186349

    Compositions and methods for C. difficile treatment

    Regents of the University of Minnesota Β· Granted Jan 7, 2025 Β· Expires Jan 2, 2045

    granted
  20. US 12186342

    Autologous irradiated whole cell tumor vaccines lentivirally engineered to express CD80, IL-15 and IL-15 receptor alpha

    The Regents of the University of California Β· Granted Jan 7, 2025 Β· Expires Jan 2, 2045

    granted
  21. US 12187698

    Crystalline forms of C21H22Cl2N4O2

    Vertex Pharmaceuticals Incorporated Β· Granted Jan 7, 2025 Β· Expires Jan 2, 2045

    granted
  22. US 12186384

    Compositions and methods for making and using thermostable immunogenic formulations with increased compatibility of use as vaccines against one or more pathogens

    The Regents of the University of Colorado, a Body Corporate Β· Granted Jan 7, 2025 Β· Expires Jan 2, 2045

    granted
  23. US 12186378

    Methods of treating skin cancer with histidine ammonia-lyase (HAL) agonists

    REGENERON PHARMACEUTICALS, INC. Β· Granted Jan 7, 2025 Β· Expires Jan 2, 2045

    granted
  24. US 12186306

    Methods of treatment for cystic fibrosis

    Vertex Pharmaceuticals Incorporated Β· Granted Jan 7, 2025 Β· Expires Jan 2, 2045

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search β€” best for looking up a specific filing or applicant portfolio slice.